These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 19441605)
21. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study. Goh BS; Ismail MI; Husain S J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303 [TBL] [Abstract][Full Text] [Related]
22. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Anolik R; Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147 [TBL] [Abstract][Full Text] [Related]
23. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF; Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048 [TBL] [Abstract][Full Text] [Related]
24. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135 [TBL] [Abstract][Full Text] [Related]
25. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis. Schoenwetter W; Lim J Clin Ther; 1995; 17(3):479-92. PubMed ID: 7585852 [TBL] [Abstract][Full Text] [Related]
26. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774 [TBL] [Abstract][Full Text] [Related]
27. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Meltzer EO; Philip G; Weinstein SF; LaForce CF; Malice MP; Dass SB; Santanello NC; Reiss TF Am J Rhinol; 2005; 19(6):591-8. PubMed ID: 16402647 [TBL] [Abstract][Full Text] [Related]
28. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. Patel P; Patel D Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452 [TBL] [Abstract][Full Text] [Related]
29. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Chervinsky P; Philip G; Malice MP; Bardelas J; Nayak A; Marchal JL; van Adelsberg J; Bousquet J; Tozzi CA; Reiss TF Ann Allergy Asthma Immunol; 2004 Mar; 92(3):367-73. PubMed ID: 15049402 [TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF; Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669 [TBL] [Abstract][Full Text] [Related]
31. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Nayak A; Langdon RB Drugs; 2007; 67(6):887-901. PubMed ID: 17428106 [TBL] [Abstract][Full Text] [Related]
32. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Mucha SM; deTineo M; Naclerio RM; Baroody FM Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874 [TBL] [Abstract][Full Text] [Related]
33. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277 [TBL] [Abstract][Full Text] [Related]
34. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma]. Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782 [TBL] [Abstract][Full Text] [Related]
35. Phenylephrine hydrochloride modified-release tablets for nasal congestion: a randomized, placebo-controlled trial in allergic rhinitis patients. Meltzer EO; Ratner PH; McGraw T Ann Allergy Asthma Immunol; 2016 Jan; 116(1):66-71. PubMed ID: 26560899 [TBL] [Abstract][Full Text] [Related]
36. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829 [TBL] [Abstract][Full Text] [Related]
37. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis]. Lu Y; Yin M; Cheng L Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 49(8):659-67. PubMed ID: 25351124 [TBL] [Abstract][Full Text] [Related]
38. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441 [TBL] [Abstract][Full Text] [Related]
39. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. Day JH; Briscoe MP; Ratz JD Allergy Asthma Proc; 2008; 29(3):304-12. PubMed ID: 18387222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]